ADAMS ADRIAN 4
4 · IMPEL NEUROPHARMA INC · Filed Aug 19, 2021
Insider Transaction Report
Form 4
ADAMS ADRIAN
DirectorCOB, CEO and President
Transactions
- Purchase
Common Stock
2021-08-18$13.81/sh+17,203$237,506→ 17,203 total - Purchase
Common Stock
2021-08-18$15.89/sh+600$9,532→ 20,000 total - Purchase
Common Stock
2021-08-18$14.91/sh+2,197$32,751→ 19,400 total
Footnotes (3)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.61 to $14.435 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.69 to $15.60 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.81 to $15.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.